Skip to content
10-Q/A

Quarterly Report

TAXUS PHARMACEUTICALS HOLDINGS, INC.

0001549727-16-000128

← back to feed
Filed
May 24, 2016 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · May 23, 2016 81.5M sh
Stockholders Equity Q3 2016 · Mar 31, 2016 $58.74K
Stockholders Equity Q3 2016 · Jun 30, 2015 $22.1K
Current Liabilities Q3 2016 · Mar 31, 2016 $9.27K
Current Liabilities Q3 2016 · Jun 30, 2015 $40.69K
Current Assets Q3 2016 · Mar 31, 2016 $57.52K
Current Assets Q3 2016 · Jun 30, 2015 $52.3K
Total Assets Q3 2016 · Mar 31, 2016 $68.01K
Total Assets Q3 2016 · Jun 30, 2015 $62.79K
Operating Cash Flow Q3 2016 · Mar 31, 2015 −$153.51K
Cash And Equivalents Q3 2016 · Mar 31, 2015 $29.42K
Cash And Equivalents Q3 2016 · Jun 30, 2014 $3.56K
Sga Expense Q3 2016 · Mar 31, 2015 $39.2K
Sga Expense Q3 2016 · Mar 31, 2015 $138.46K
Net Income Q3 2016 · Mar 31, 2015 −$31.77K
Net Income Q3 2016 · Mar 31, 2015 −$108.83K
Gross Profit Q3 2016 · Mar 31, 2015 $7.42K
Gross Profit Q3 2016 · Mar 31, 2015 $29.63K
Cost Of Revenue Q3 2016 · Mar 31, 2015 $16.14K
Cost Of Revenue Q3 2016 · Mar 31, 2015 $44.02K
Revenue Q3 2016 · Mar 31, 2015 $23.56K
Revenue Q3 2016 · Mar 31, 2015 $73.65K